Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other financing activities: 2009-2024

Historic Other financing activities for Capricor Therapeutics (CAPR) over the last 11 years, with Dec 2024 value amounting to $9.8 million.

  • Capricor Therapeutics' Other financing activities rose 23.31% to $2.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.8 million, marking a year-over-year increase of 32.10%. This contributed to the annual value of $9.8 million for FY2024, which is 32.10% up from last year.
  • Capricor Therapeutics' Other financing activities amounted to $9.8 million in FY2024, which was up 32.10% from $7.4 million recorded in FY2023.
  • Capricor Therapeutics' Other financing activities' 5-year high stood at $9.8 million during FY2024, with a 5-year trough of $2.0 million in FY2020.
  • Over the past 3 years, Capricor Therapeutics' median Other financing activities value was $7.4 million (recorded in 2023), while the average stood at $7.2 million.
  • Data for Capricor Therapeutics' Other financing activities shows a peak YoY surged of 178.56% (in 2020) over the last 5 years.
  • Over the past 5 years, Capricor Therapeutics' Other financing activities (Yearly) stood at $2.0 million in 2020, then soared by 51.88% to $3.0 million in 2021, then spiked by 50.34% to $4.5 million in 2022, then soared by 65.80% to $7.4 million in 2023, then soared by 32.10% to $9.8 million in 2024.